Identification of Pharmacophore Groups with Antimalarial Potential in Flavonoids by QSAR-Based Virtual Screening
Background/Objectives: Severe malaria, mainly caused by Plasmodium falciparum, remains a significant therapeutic challenge due to increasing drug resistance and adverse effects. Flavonoids, known for their wide range of bioactivities, offer a promising route for antimalarial drug discovery. The aim of this study was to elucidate key structural features associated with antimalarial activity in flavonoids and to develop accurate, interpretable predictive models. Methods: Curated databases of flavonoid structures and their activity against P. falciparum strains and enzymes were constructed. Molecular fingerprinting and decision tree analyses were used to identify key pharmacophoric groups. Subsequently, molecular descriptors were generated and reduced to build multiple classification and regression models. Results: These models demonstrated high predictive accuracy, with test set accuracies ranging from 92.85% to 100%, and R2 values from 0.64 to 0.97. Virtual screening identified novel flavonoid candidates with potential inhibitory activity. These were further evaluated using molecular docking and molecular dynamics simulations to assess binding affinity and stability with Plasmodium proteins (FabG, FabZ, and FabI). The predicted active ligands exhibited stable pharmacophore interactions with key protein residues, providing insights into binding mechanisms. Conclusions: This study provides highly predictive models for antimalarial flavonoids and enhances the understanding of structure–activity relationships, offering a strong foundation for further experimental validation.
Authors
- Marcel Bermúdez (ORCID: https://orcid.org/0000-0002-7421-3282)
- Adriana de Oliveira Fernandes
- Tiago Branquinho Oliveira (ORCID: https://orcid.org/0000-0001-7578-9497)
- Aurélia Santos Faraoni
- Eduardo Borba Alves (ORCID: https://orcid.org/0000-0002-1778-7001)
- Daniela Aparecida Chagas‐Paula (ORCID: https://orcid.org/0000-0003-2274-4919)
- Silvio Santana Dolabella (ORCID: https://orcid.org/0000-0001-5576-3214)
- Rosana Casoti (ORCID: https://orcid.org/0000-0003-4105-1392)
- Marcus Vinícius de Aragão Batista (ORCID: https://orcid.org/0000-0003-4745-8919)
- Ricardo Pereira Rodrigues (ORCID: https://orcid.org/0000-0002-2924-0468)
- Yria Jaine Andrade Santos (ORCID: https://orcid.org/0009-0006-2480-7978)
- Valéria Vieira Moura Paixão
Institutions
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Universidade Federal de Sergipe (BR)
- University of Münster (DE)
- Universidade Federal de Alfenas (BR)
- Universidade Federal de Pernambuco (BR)
Publication Details
- Journal
- Drugs and Drug Candidates
- Published
- 2025-07-04
- DOI
- https://doi.org/10.3390/ddc4030033
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00